Literature DB >> 24077997

Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.

Hiroyuki Yamada, Masao Hosokawa, Kazuo Itoh, Toshinao Takenouchi, Yoshihiro Kinoshita, Tomohiro Kikkawa, Keita Sakashita, Shion Uemura, Yasunori Nishida, Takaya Kusumi, Shigeyuki Sasaki.   

Abstract

PURPOSE: This study investigated the diagnostic accuracy of hybrid positron-emission tomography/computed tomography (PET/CT) for lymph node (LN) metastasis of esophageal cancer. We also investigated the correlation between the size of metastatic nests and the detection by PET/CT.
METHODS: Two hundred and fifty-eight patients with esophageal squamous cell carcinoma who underwent esophagectomy with two- or three-field radical lymphadenectomy were analyzed retrospectively. We compared the diagnosis of preoperative PET/CT to the postoperative histopathological examination by each anatomical field (n = 1,231) in all 258 patients. The metastatic LNs resected from PET/CT positive fields were classified as belonging to the PET/CT-N-positive group (n = 229) and those from negative fields as belonging to the PET/CT-N-negative group (n = 352). The cross-sectional areas of metastatic nests were measured in each metastatic LN.
RESULTS: Of the 1,231 fields, 275 (22 %) were positive for metastasis, including 581 LNs from 408 regional LN stations. The sensitivity and specificity of PET/CT examined by each anatomical field were 25.8 and 97.8 %, respectively. The median area of metastatic nests was 17.7 mm2 in the PET/CT-N-positive group, and 7.7 mm2 in the PET/CT-N-negative group (p < 0.001).
CONCLUSIONS: A significant correlation was suggested between the nest size and detection by PET/CT. Because of its low sensitivity, PET/CT alone is insufficient to determine the surgical procedures, especially when considering reduction surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24077997     DOI: 10.1007/s00595-013-0725-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.

Authors:  Masahiro Okada; Takamichi Murakami; Seishi Kumano; Masatomo Kuwabara; Taro Shimono; Makoto Hosono; Hitoshi Shiozaki
Journal:  Ann Nucl Med       Date:  2009-02-11       Impact factor: 2.668

2.  Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma.

Authors:  F Wang; L-Y Shen; S-H Ma; N Li; Z Yang; K-N Chen
Journal:  Dis Esophagus       Date:  2012-09-04       Impact factor: 3.429

3.  Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.

Authors:  Yoshihiro Kakeji; Manabu Yamamoto; Shuhei Ito; Masahiko Sugiyama; Akinori Egashira; Hiroshi Saeki; Masaru Morita; Yoshihisa Sakaguchi; Yasushi Toh; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-01-14       Impact factor: 2.549

4.  Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.

Authors:  Hiroyuki Kato; Hiroyuki Kuwano; Masanobu Nakajima; Tatsuya Miyazaki; Minako Yoshikawa; Hitoshi Ojima; Katsuhiko Tsukada; Noboru Oriuchi; Tomio Inoue; Keigo Endo
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

5.  F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.

Authors:  Shunsuke Tanabe; Yoshio Naomoto; Yasuhiro Shirakawa; Yasuhiro Fujiwara; Kazufumi Sakurama; Kazuhiro Noma; Munenori Takaoka; Tomoki Yamatsuji; Takao Hiraki; Yoshihiro Okumura; Masahiko Mitani; Mitsumasa Kaji; Susumu Kanazawa; Toshiyoshi Fujiwara
Journal:  Clin Nucl Med       Date:  2011-10       Impact factor: 7.794

6.  Diabetes Decreases FDG Accumulation in Primary Lung Cancer.

Authors:  Tatsuo Torizuka; Kenneth R. Zasadny; Richard L. Wahl
Journal:  Clin Positron Imaging       Date:  1999-10

Review 7.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

8.  Radical lymph node dissection for cancer of the thoracic esophagus.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

9.  Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

Authors:  P Lindholm; H Minn; S Leskinen-Kallio; J Bergman; U Ruotsalainen; H Joensuu
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057

10.  Influence of Diabetes on the Interpretation of PET Scans in Patients With Esophageal Cancer.

Authors:  Michael Haley; Andre Konski; Tianyu Li; Jonathan D Cheng; Alan Maurer; Oleh Haluszka; Walter Scott; Neal J Meropol; Steven J Cohen; Gary Freedman
Journal:  Gastrointest Cancer Res       Date:  2009-07
View more
  11 in total

1.  A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer.

Authors:  Jae Kil Park; Jae Jun Kim; Seok Whan Moon
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Chenxue Jiang; Yun Chen; Yaoyao Zhu; Yapping Xu
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

3.  Tubular adenoma of the common bile duct with uptake in 18F-FDG PET: A case report.

Authors:  Kentaro Hokonohara; Takehiro Noda; Hisanori Hatano; Akihiro Takata; Masashi Hirota; Kazuteru Oshima; Tsukasa Tanida; Takamichi Komori; Shunji Morita; Hiroshi Imamura; Takashi Iwazawa; Kenzo Akagi; Shiro Hayashi; Masami Inada; Shiro Adachi; Keizo Dono
Journal:  Mol Clin Oncol       Date:  2015-11-09

4.  Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation.

Authors:  Brandon Garcia; Karyn A Goodman; Lajhem Cambridge; Mark Dunphy; Abraham J Wu
Journal:  Radiat Oncol       Date:  2016-11-25       Impact factor: 3.481

5.  Diagnostic value of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for preoperative lymph node metastasis of esophageal cancer: A meta-analysis.

Authors:  Jingfeng Hu; Dengyan Zhu; Yang Yang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer.

Authors:  Mamoru Uemura; Masataka Ikeda; Rio Handa; Katsuki Danno; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Tsunekazu Mizushima; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Hidetoshi Eguchi
Journal:  BMC Cancer       Date:  2021-10-21       Impact factor: 4.430

7.  Modified method to improve the diagnostic efficiency of 18F-FDG PET/CT in regional lymph node metastasis of esophageal squamous cell carcinoma.

Authors:  Siqin Liao; Wenwei Wei; Shuliang Zhang; Taidui Zeng; Hao Chen; Wei Zheng; Chun Chen; Zhongyou Ji; Bin Zheng
Journal:  Ann Transl Med       Date:  2021-10

8.  Usefulness of positron emission tomography-computed tomography in pre-operative evaluation of intra-thoracic esophageal cancer.

Authors:  Jae Jun Kim; Jae Kil Park; Seok Whan Moon
Journal:  Thorac Cancer       Date:  2015-03-06       Impact factor: 3.500

9.  Mediastinal node staging by positron emission tomography-computed tomography and selective endoscopic ultrasound with fine needle aspiration for patients with upper gastrointestinal cancer: Results from a regional centre.

Authors:  Chris Harrington; Lyn Smith; Jennifer Bisland; Elisabet López González; Neil Jamieson; Stuart Paterson; Adrian John Stanley
Journal:  World J Gastrointest Endosc       Date:  2018-01-16

Review 10.  Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature.

Authors:  Hideaki Shimada; Takeo Fukagawa; Yoshio Haga; Shin-Ichi Okazumi; Koji Oba
Journal:  Ann Gastroenterol Surg       Date:  2021-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.